Abstract
Clin Microbiol Infect 2012; 18: 862-869 Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥48h after hospital admission (HCA≥48h), HCA SAB with onset
| Original language | English |
|---|---|
| Pages (from-to) | 862-869 |
| Number of pages | 8 |
| Journal | Clinical Microbiology and Infection |
| Volume | 18 |
| Issue number | 9 |
| DOIs | |
| Publication status | Published - Sep 2012 |
Fingerprint
Keywords
- Healthcare-associated
- Methicillin-resistance
- Mortality
- Staphylococcus aureus
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases
Cite this
Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia. / Bassetti, M.; Trecarichi, E. M.; Mesini, A.; Spanu, T.; Giacobbe, D. R.; Rossi, M.; Shenone, E.; Pascale, G. D.; Molinari, M. P.; Cauda, R.; Viscoli, C.; Tumbarello, M.
In: Clinical Microbiology and Infection, Vol. 18, No. 9, 09.2012, p. 862-869.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Risk factors and mortality of healthcare-associated and community-acquired Staphylococcus aureus bacteraemia
AU - Bassetti, M.
AU - Trecarichi, E. M.
AU - Mesini, A.
AU - Spanu, T.
AU - Giacobbe, D. R.
AU - Rossi, M.
AU - Shenone, E.
AU - Pascale, G. D.
AU - Molinari, M. P.
AU - Cauda, R.
AU - Viscoli, C.
AU - Tumbarello, M.
PY - 2012/9
Y1 - 2012/9
N2 - Clin Microbiol Infect 2012; 18: 862-869 Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥48h after hospital admission (HCA≥48h), HCA SAB with onset
AB - Clin Microbiol Infect 2012; 18: 862-869 Staphylococcus aureus bacteraemia (SAB) is a leading cause of mortality and morbidity in both nosocomial and community settings. The objective of the study is to explore epidemiological characteristics and predisposing risk factors associated with healthcare-associated (HCA) and community-acquired (CA) SAB, and to evaluate any differences in mortality and efficacy of initial antimicrobial therapy on treatment outcome. We conducted a two-part analysis. First, a triple case-control study in which groups of HCA SAB with onset ≥48h after hospital admission (HCA≥48h), HCA SAB with onset
KW - Healthcare-associated
KW - Methicillin-resistance
KW - Mortality
KW - Staphylococcus aureus
UR - http://www.scopus.com/inward/record.url?scp=84865285121&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84865285121&partnerID=8YFLogxK
U2 - 10.1111/j.1469-0691.2011.03679.x
DO - 10.1111/j.1469-0691.2011.03679.x
M3 - Article
C2 - 21999245
AN - SCOPUS:84865285121
VL - 18
SP - 862
EP - 869
JO - Clinical Microbiology and Infection
JF - Clinical Microbiology and Infection
SN - 1198-743X
IS - 9
ER -